Target intelligence / Profile preview

Arabinosyltransferase A (embA)

Target
embA
Molecular classification
Enzyme, Glycosyltransferase, Arabinofuranosyltransferase
01

Overview

Arabinosyltransferase A (embA) is an essential enzyme in mycobacteria, particularly Mycobacterium tuberculosis, responsible for the polymerization of arabinose into the arabinan domain of arabinogalactan, a crucial component of the mycobacterial cell wall. It functions as a validated drug target, with inhibition leading to cessation of cell wall biosynthesis. Ethambutol, a first-line anti-tuberculosis drug, targets this enzyme and related arabinosyltransferases.

02

Mechanism of action

Inhibition of arabinosyltransferase activity, leading to disruption of cell wall biosynthesis

03

Biological functions

Cell wall biosynthesisArabinan polymerizationArabinogalactan synthesisLipoarabinomannan (LAM) synthesis
04

Disease associations

InfectionTuberculosis
05

Safety considerations

Essentiality in M. tuberculosis makes complete inhibition potentially lethal to the organism; resistance can develop via mutations in related genes (e.g., embB)
06

Interacting drugs

Ethambutol

Beyond the preview

Go deeper on Arabinosyltransferase A (embA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arabinosyltransferase A (embA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call